AleynRay Launches Free PDF Editor With More Than 100 Privacy-First Browser Tools

The free online PDF editor requires no signup, adds no watermarks, imposes no fixed daily limits, and processes ...
The Chosun Ilbo on MSN

Kolon TissueGene's TG-C fails US phase 3 trial, delaying commercialization

C’ (formerly Invossa) failed to demonstrate therapeutic efficacy in its first U.S. Phase 3 clinical trial. Jeon Seung-ho, ...